The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
A dangerous hospital superbug, Pseudomonas aeruginosa, can now digest medical plastic like sutures and implants, microbiologists reveal. This alarming ability allows the pathogen to survive longer and form tougher antibiotic-resistant biofilms, posing a significant new threat to patient safety in healthcare settings.
Obesity is a growing problem around the world, with many negative consequences for both individuals and societies. Research by Professor Barry M. Popkin and his colleagues at the University of North Carolina (UNC) aims to lead us beyond the current obesity epidemic.
Karen Moor and Marlies Wijsenbeek from the Erasmus Medical Center, Rotterdam explore the role of eHealth tools in idiopathic pulmonary fibrosis care and research.
Digitally enabled pathway personalisation is leveraging actionable data insights and dynamic intelligence to drive better outcomes as part of the Prevention 3.0 agenda
Hundreds of survivors of female genital mutilation (FGM) will be able to access expert care, support and treatment due to a new network of NHS clinics being launched.
Today (12 September) the NHS Confederation responded to the publication of Operation Yellowhammer, a document describing alarming food and medicine shortages after Brexit.
In this interview, Jean-Marie Dangou from the WHO Regional Office for Africa discusses diabetes in the African region, including lack of access to treatment and ongoing action to solve this.
Dr Gerry Morrow shares his thoughts on the precision medicine, defined as the cost-effectiveness of breakthrough treatments and explains why this area is a priority for both researchers and government.
Nick Bennett, CEO at Fika, puts forward the case for a positive and preventative approach to mental health for university students, drawing on learnings from physical fitness and positive psychology.
Shinichi Tokuno from the Department of Voice Analysis of Pathophysiology, Graduate School of Medicine, at the University of Tokyo, lifts the lid on voice analysis technology for healthcare.
As government authorities come to grips with legislation of cannabis-based products, the European market holds a key position, Liam McGreevy, CEO, Ethnopharm Ltd explains.
Patients will benefit from significant government investment in new NHS technology to improve treatment, diagnosis and care options for diseases including cancer.
A recent European Monitoring Centre for Drugs and Drug Addiction report highlights the need for diversity of cannabis products, increased potency and close monitoring of health effects.
Researchers from SACIDS Foundation for One Health discuss the importance and implementation of event-based community surveillance using a One Health approaches in East and Southern Africa.
